How Much Does Genvoya Cost?
Genvoya (Elvitegravir/Cobicistat/Emtricitabine/TAF) costs an average of $3,619 per Medicare Part D claim, with total Medicare spending of $2345.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $3,619 |
| Total Medicare Spending | $2345.0M |
| Total Claims | 648,000 |
| Beneficiaries | 54,000 |
| Generic Available | Yes |
| Year-Over-Year Change | -8.4% |
Genvoya (Elvitegravir/Cobicistat/Emtricitabine/TAF) costs an average of $3,619 per Medicare Part D claim, with total Medicare spending of $2345.0M in the latest year. A generic version is available, which may reduce out-of-pocket costs.